NCT04615624View on ClinicalTrials.gov

Furosemide vs. Placebo for Severe Antepartum Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

April 22, 2022

Study Completion Date

April 29, 2022

Conditions
Pre-EclampsiaHypertension in PregnancyPregnancy ComplicationsHypertension, Pregnancy-Induced
Interventions
DRUG

Furosemide

Furosemide, a loop diuretic

OTHER

Placebo

Normal saline

Trial Locations (1)

96826

Kapiolani Medical Center for Women and Children, Honolulu

All Listed Sponsors
lead

Melanie Maykin, MD

OTHER

NCT04615624 - Furosemide vs. Placebo for Severe Antepartum Hypertension | Biotech Hunter | Biotech Hunter